Clinical trial regulation can be intimidating. The regulation of regenerative medicines: cell, gene, immune and tissue engineered therapeutics can appear impossible. However, key members of the IPAV team, along with trusted academic collaborators have proved that it isn’t.

James Smith and colleagues have recently published the leading guide to regenerative medicine regulation in the RAPS Fundamentals of US Regulatory Affairs, Ninth Edition, the core text for the Regulatory Affairs Certificate. IPAV are long-term supporters of the RAC, and the deep technical understanding demonstrated by charter holders – members of IPAV and in its client organisations.

IPAV look forward to contributing to the forthcoming RAPS annual conference in Baltimore http://www.raps.org/convergence/ and helping its clients connect with RAC certified professions within its network. Finding a great regulatory consultant is like finding the high school teacher that fundamentally impacted your life. Fortunately, we know many of them.